Chembio Diagnostics, Inc.
NASDAQ: CEMI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Richard L. Eberly
- Employees
- 188
- Headquarters
- Hauppauge, United States
- IPO year
- 2000
- Market cap
- $16.7M
- Website
- https://chembio.com
Loading CEMI…
Loading profile data…Frequently asked questions about CEMI
What does Chembio Diagnostics, Inc. (CEMI) do?
Chembio Diagnostics, Inc., along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus. Beyond these, the comp...
Where does CEMI trade?
Chembio Diagnostics, Inc. (CEMI) trades on the NASDAQ Capital Market.
What sector is CEMI in?
Chembio Diagnostics, Inc. (CEMI) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Chembio Diagnostics, Inc.?
Richard L. Eberly is the chief executive officer of Chembio Diagnostics, Inc. (CEMI).
Where is Chembio Diagnostics, Inc. headquartered?
Chembio Diagnostics, Inc. is headquartered in United States.
Does CEMI pay a dividend?
Chembio Diagnostics, Inc. (CEMI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CEMI go public?
Chembio Diagnostics, Inc. (CEMI) completed its initial public offering in 2000.